- New
Catalog # PE71176
Human C2a 73 kDa Protein (catalog number PE71176) is a complement research reagent from Novatein Biosciences. Size: 30 µg/vial 1.0 mg/ml.
The larger fragment of complement protein C2 is C2a that results from the activation of the classical and lectin pathways. C2a forms the proteolytic subunit of the C3 and C5 convertase of both pathways. Initiation of each pathway generates proteolytic enzyme complexes which are bound to the target surface (C1q/C1r/C1s in the classical pathway and MBL/ Ficolin/ MASPs in the lectin pathway). C1s and MASP in these complexes activate both C4 and C2. They cleave a peptide bond in C4 depositing C4b on the surface. They also cleave C2 into two fragments, the larger catalytic fragment C2a (73 kDa) and the smaller fragment C2b (34 kDa). The larger fragment binds to C4b and forms the C3/C5 convertase enzyme complex C4b,C2a, which activates C3, cleaving it to C3b and C3a. Deposition C3b on or near the C4b,C2a site converts the C3/C5 converatse, which is a weak C5 convertase, to a highly efficient C5 convertase (C4b,C2a,C3b) with a Km for C5 3000-fold lower than that of the C4b,C2a enzyme alone. Upon cleavage of C2 by C1s or MASP two fragments are produced. The larger, C2a, with 509 amino acids forms the C3/C5 convertase of the classical and lectin pathways. C2a comes from the C-terminal of C2 while the smaller fragment, C2b, with 223 amino acids is from the N- terminal. Both contain carbohydrate. C2 has numerous allotypes (A, B, and C) and electrophoretic isoforms that can be separated by isoelectric focusing. The isoforms have pIs in the 6.0 to 6.3 pH range. C4BP regulates the functional activity of C2 during complement activation. The C4b,C2a complex is inherently unstable with a natural half-life of several minutes at 37o C. In the presence of C4BP the decay of this complex is shortened to seconds due to the decay accelerating activity of C4BP. This activity of C4BP on C4b,C2a is similar to the decay accelerating activity of factor H on C3b,Bb. Another similarity between factor H and C4BP is that once bound to their targets (C3b or C4b, respectively) they act as cofactors for cleavage by factor I. When C4BP binds to C4b,C2a the C2a is rapidly released and factor I cleaves the alpha chain of C4b producing iC4b. Thus, the site for C2a binding is destroyed and additional C3/C5 convertases cannot be formed.
Human C2a (larger fragment) is composed of a single polypeptide chain. The molecular size of C2a has been reported to be 73,000 Dalton as determined by SDS/polyacrylamide gel electrophoresis gels. C2a contains two domains one of which is a von Willebrand factor-like A (vWFA) domain that binds to Mg++ and to C4b and the other, the C-terminal domain, contains the active serine protease (SP) site. The crystal structure for the Mg2+-bound C2a at 1.9 angstrom resolution has been published. The concentration of purified human C2a is determined by using the calculated extinction coefficient based on the amino acid sequence of C2a using ProtParam and assumes all pairs of Cys residues form cystines (i.e., a pair of cystine molecules are joined by a disulfide bond).
There are no convenient assays for the proteolytic activity of C2a. It is usually referred to as inactive after its release from C2.